Formulation Development

• API or formulated API in a bottle or capsule
• Immediate, modified, and sustained release tablets
• Multiparticulates, mini-tablets and granules
• Liquid filled capsules
• Orally disintegrating tablets (ODT)

• Dry powders
• Solutions
• Suspensions

• Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)

• Topical
• Rectal

• Aqueous and non-aqueous liquids
• Suspensions and nanosuspensions

With over 30 years of experience, we provide full-service support for small molecule drug programs, from dosage formulation development to GMP clinical trial manufacturing and commercial drug product supply.

We focus on delivering the most appropriate formulations, however complex, to expedite your clinical program. We support rapid progression to your first-in-human evaluation and ensure that your lead drug product can be seamlessly transitioned through development and scale-up. Using our expertise, we help you identify any issues that would impede scale up, so you can be set up for commercial success. 

We have state-of-the-art, recently upgraded pharmaceutical development and clinical manufacturing facilities in the US and UK.

Our unique approach to drug product optimization saves time and increases the potential for success by facilitating decisions based on real-time clinical data. We have completed over 300 drug product formulation optimization programs and have clinically evaluated more than 1,000 formulations. 

We have deep expertise in formulation development, built across more than 30 years and over 1,500 molecules developed.

Our innovative approach to formulation development is based on our proven track record in delivering phase-appropriate formulations across the product development pathway, from preclinical to late-stage development.